Apellis Pharma

Apellis Pharma Faces Stock Plummet as European Regulator Hints at Negative Verdict on Pegcetacoplan! Will This Groundbreaking Treatment for Blindness Survive?”

December 14, 2023

0 444

Apellis Pharma Faces Stock Plummet as European Regulator Hints at Negative Verdict on Pegcetacoplan! Will This Groundbreaking Treatment for Blindness Survive?”

Apellis Pharma (APLS) stock faced a significant pre-market downturn after news surfaced regarding the company’s anticipation of a negative opinion…